Abstract
Dysregulation of the GC system permitting excessive inflammation in the presence of elevated GCs occurs in depression, and is thought to be due to impaired GC signalling. We propose FKBP5, which acts to reduce GR activation, has a role in GC dysregulation. Glucocorticoid induced leucine zipper (GILZ) is a GC-inducible gene that is used as a readout of GR activation. The current objective was to examine the ability of IFN-α, IL-6, TNF-α, and IL-1β to impact GC sensitivity in microglia. These cytokines were chosen due to their implication in depression. The ability of these cytokines to alter mRNA expression of GR, FKBP5 and GILZ under basal conditions and in response to dexamethasone (DEX) in BV2 microglia was examined. Both IL-6 and IFN-α attenuated DEX-induced increases of GILZ, indicating the presence of GC resistance. IFN-α increased basal expression of FKBP5 and consistent with its negative feedback function attenuated DEX-induced FKBP5 expression. IL-6 did not alter basal expression of GR, FKBP5 or GILZ, but did attenuate the DEX-induced increases of FKBP5 and GILZ. Immunofluorescent staining shows that IFN-αand IL-6 reduce the degree of DEX-induced GR translocation and that IFN-α increased the co-localisation of GR and FKBP5. Taken together, IFN-α and IL-6 induce GC resistance in microglia and we hypothesise that IFN-α-induced increases in FKBP5 result in GR being held in the cytosol thereby preventing GC signalling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.